Keel Point’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$339K Buy
7,326
+526
+8% +$24.3K 0.02% 375
2025
Q1
$415K Buy
6,800
+1,152
+20% +$70.3K 0.03% 288
2024
Q4
$319K Buy
5,648
+642
+13% +$36.3K 0.03% 317
2024
Q3
$259K Buy
5,006
+104
+2% +$5.38K 0.02% 363
2024
Q2
$240K Buy
4,902
+575
+13% +$28.2K 0.02% 372
2024
Q1
$235K Buy
+4,327
New +$235K 0.02% 335
2023
Q4
Sell
-3,972
Closed -$231K 353
2023
Q3
$231K Sell
3,972
-347
-8% -$20.1K 0.03% 274
2023
Q2
$276K Buy
4,319
+851
+25% +$54.4K 0.04% 258
2023
Q1
$240K Sell
3,468
-104
-3% -$7.21K 0.03% 263
2022
Q4
$257K Buy
3,572
+743
+26% +$53.5K 0.04% 244
2022
Q3
$201K Buy
2,829
+23
+0.8% +$1.63K 0.03% 237
2022
Q2
$210K Sell
2,806
-263
-9% -$19.7K 0.03% 237
2022
Q1
$224K Buy
+3,069
New +$224K 0.03% 236
2019
Q1
Sell
-6,355
Closed -$330K 195
2018
Q4
$330K Sell
6,355
-450
-7% -$23.4K 0.04% 148
2018
Q3
$422K Buy
6,805
+480
+8% +$29.8K 0.05% 116
2018
Q2
$350K Hold
6,325
0.05% 120
2018
Q1
$400K Hold
6,325
0.05% 106
2017
Q4
$388K Hold
6,325
0.05% 114
2017
Q3
$403K Hold
6,325
0.06% 113
2017
Q2
$352K Buy
6,325
+39
+0.6% +$2.17K 0.07% 111
2017
Q1
$342K Buy
6,286
+18
+0.3% +$979 0.07% 113
2016
Q4
$366K Sell
6,268
-1,697
-21% -$99.1K 0.08% 103
2016
Q3
$429K Hold
7,965
0.16% 87
2016
Q2
$586K Hold
7,965
0.25% 71
2016
Q1
$509K Sell
7,965
-346
-4% -$22.1K 0.26% 67
2015
Q4
$572K Sell
8,311
-133
-2% -$9.15K 0.31% 65
2015
Q3
$500K Sell
8,444
-291
-3% -$17.2K 0.28% 55
2015
Q2
$584K Buy
8,735
+384
+5% +$25.7K 0.28% 54
2015
Q1
$539K Buy
+8,351
New +$539K 0.27% 57